- Home
- PBPB vs ARCT Comparison
PBPB vs ARCT Comparison
Compare PBPB & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBPB
- ARCT
- Stock Information
- Founded
- PBPB 1977
- ARCT 2013
- Country
- PBPB United States
- ARCT United States
- Employees
- PBPB N/A
- ARCT N/A
- Industry
- PBPB Restaurants
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- PBPB Consumer Discretionary
- ARCT Health Care
- Exchange
- PBPB Nasdaq
- ARCT Nasdaq
- Market Cap
- PBPB 255.4M
- ARCT 298.3M
- IPO Year
- PBPB 2013
- ARCT N/A
- Fundamental
- Price
- PBPB $9.87
- ARCT $10.98
- Analyst Decision
- PBPB Strong Buy
- ARCT Strong Buy
- Analyst Count
- PBPB 3
- ARCT 7
- Target Price
- PBPB $15.33
- ARCT $57.80
- AVG Volume (30 Days)
- PBPB 241.5K
- ARCT 372.7K
- Earning Date
- PBPB 05-07-2025
- ARCT 05-12-2025
- Dividend Yield
- PBPB N/A
- ARCT N/A
- EPS Growth
- PBPB 1009.90
- ARCT N/A
- EPS
- PBPB 1.39
- ARCT N/A
- Revenue
- PBPB $465,126,000.00
- ARCT $152,310,000.00
- Revenue This Year
- PBPB $5.17
- ARCT N/A
- Revenue Next Year
- PBPB $5.58
- ARCT $44.93
- P/E Ratio
- PBPB $7.07
- ARCT N/A
- Revenue Growth
- PBPB N/A
- ARCT N/A
- 52 Week Low
- PBPB $6.28
- ARCT $8.04
- 52 Week High
- PBPB $13.48
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- PBPB 63.83
- ARCT 42.59
- Support Level
- PBPB $8.24
- ARCT $10.70
- Resistance Level
- PBPB $10.61
- ARCT $13.10
- Average True Range (ATR)
- PBPB 0.41
- ARCT 0.83
- MACD
- PBPB 0.27
- ARCT -0.05
- Stochastic Oscillator
- PBPB 74.13
- ARCT 9.46
About PBPB Potbelly Corporation
Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.